BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 25758200)

  • 21. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
    Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
    J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion.
    Hayashi H; Nabeshima K; Aoki M; Hamasaki M; Enatsu S; Yamauchi Y; Yamashita Y; Iwasaki H
    Int J Cancer; 2010 Jun; 126(11):2563-74. PubMed ID: 19856315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.
    Li X; Wang J; Zhang X; Zeng Y; Liang L; Ding Y
    Ann Surg Oncol; 2012 Jan; 19(1):145-53. PubMed ID: 21861235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased expression of microRNA-625 is associated with tumor metastasis and poor prognosis in patients with colorectal cancer.
    Lou X; Qi X; Zhang Y; Long H; Yang J
    J Surg Oncol; 2013 Sep; 108(4):230-5. PubMed ID: 23861214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer.
    Ma F; Bi L; Yang G; Zhang M; Liu C; Zhao Y; Wang Y; Wang J; Bai Y; Zhang Y
    Oncol Rep; 2014 Sep; 32(3):1071-7. PubMed ID: 25017610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of Bcl-xL gene expression in human colorectal cancer.
    Jin-Song Y; Zhao-Xia W; Cheng-Yu L; Xiao-Di L; Ming S; Yuan-Yuan G; Wei D
    Acta Histochem; 2011 Dec; 113(8):810-4. PubMed ID: 21277008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of vinculin and membrane-bound β-catenin promotes metastasis and predicts poor prognosis in colorectal cancer.
    Li T; Guo H; Song Y; Zhao X; Shi Y; Lu Y; Hu S; Nie Y; Fan D; Wu K
    Mol Cancer; 2014 Dec; 13():263. PubMed ID: 25496021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of alpha-, beta- and gamma-synuclein in colorectal cancer, and potential clinical significance in progression of the disease.
    Ye Q; Wang TF; Peng YF; Xie J; Feng B; Qiu MY; Li LH; Lu AG; Liu BY; Zheng MH
    Oncol Rep; 2010 Feb; 23(2):429-36. PubMed ID: 20043104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.
    Zhou T; Zhang GJ; Zhou H; Xiao HX; Li Y
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):229-33. PubMed ID: 24150523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
    Wang J; Zhao X; Jin L; Wu G; Yang Y
    Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma.
    Mesci A; Taeb S; Huang X; Jairath R; Sivaloganathan D; Liu SK
    World J Gastroenterol; 2014 Dec; 20(46):17376-87. PubMed ID: 25516649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma.
    Li X; Liang L; Huang L; Ma X; Li D; Cai S
    Mol Cancer; 2015 Apr; 14():95. PubMed ID: 25927939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of GAB2, a scaffolding/docking protein acting downstream of EGFR in human colorectal cancer.
    Matsumura T; Sugimachi K; Takahashi Y; Uchi R; Sawada G; Ueda M; Hirata H; Sakimura S; Ueo H; Takano Y; Kurashige J; Shinden Y; Eguchi H; Sudo T; Yamamoto H; Doki Y; Mori M; Mimori K
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S743-9. PubMed ID: 25029990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of FMNL2 is closely related to metastasis of colorectal cancer.
    Zhu XL; Liang L; Ding YQ
    Int J Colorectal Dis; 2008 Nov; 23(11):1041-7. PubMed ID: 18665374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TLE4 promotes colorectal cancer progression through activation of JNK/c-Jun signaling pathway.
    Wang SY; Gao K; Deng DL; Cai JJ; Xiao ZY; He LQ; Jiao HL; Ye YP; Yang RW; Li TT; Liang L; Liao WT; Ding YQ
    Oncotarget; 2016 Jan; 7(3):2878-88. PubMed ID: 26701208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer.
    Xu L; Li X; Cai M; Chen J; Li X; Wu WK; Kang W; Tong J; To KF; Guan XY; Sung JJ; Chan FK; Yu J
    Gut; 2016 Apr; 65(4):635-46. PubMed ID: 25947013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
    Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
    Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.